NEWS

Navinta received FDA approval (May 13, 2025) ANDA 217880, MARAVIROC

​

Navinta received FDA approval (March 14, 2025) ANDA 219111, MIGLUSTAT

​

Navinta received FDA approval (February 3, 2025) ANDA 218966, SEVELAMER HYDROCHLORIDE

​

Navinta received FDA approval (July 14, 2023) ANDA 217526, SODIUM PHENYL ACETATE and SODIUM BENZOATE.

​

Navinta received FDA approval (June 22, 2022) ANDA 213395, CARGLUMIC ACID

​

Navinta received FDA approval (October 8, 2021) ANDA 214363, PENICILLAMINE.

 

Navinta received FDA approval (October 13, 2020) ANDA 210594,

REMIFENTANIL HYDROCHLORIDE.

​

Navinta received FDA approval (August 20, 2020) ANDA 212957, FOSAPREPITANT.

​

Navinta received FDA approval (January 16, 2019) ANDA 211251,

TRIENTINE HYDROCHLORIDE.

​

Navinta received FDA approval (September 11, 2018) ANDA 210179, CARMUSTINE.